vimarsana.com
Home
Live Updates
UCB and Praxis Precision Medicines Announce Epilepsy Research Collaboration : comparemela.com
UCB and Praxis Precision Medicines Announce Epilepsy Research Collaboration
BRUSSELS (Belgium) and BOSTON, Massachusetts (USA), December 13th, 2022 (22:01 CET) — UCB, a global biopharmaceutical company (EURONEXT BRUSSELS: UCB), and Praxis Precision Medicines, Inc.
Related Keywords
Boston ,
Massachusetts ,
United States ,
Brussels ,
Bruxelles Capitale ,
Belgium ,
Dhaval Patel ,
Marcio Souza ,
Twitter ,
Praxis Precision Medicines Inc ,
Nasdaq ,
Praxis Precision Medicines ,
Euronext Brussels ,
Alliance ,
Disease ,
Forward Looking Statement ,
Information Technology ,
Partnership ,
Economy Of Belgium ,
Epilepsy ,
Euronext ,
Ucb ,
comparemela.com © 2020. All Rights Reserved.